Relier Pairs Diabetes Oral MedsVersion en ligne NUr115 Oral Diabetic Agents par Concetta Fiorentino 1 Enhances glucose-dependent insulin secretion. 2 Prevents kidneys from reabsorbing glucose. 3 Do not increased insulin secretion. 4 Possible side-effect of impaired platelet function. 5 Stimulate beta cells of the pancreas. 6 Usually given once a day. 7 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. 8 Sensitize body tissue to insulin: stimulates insulin receptor sites. 9 Inhibit production of glucose by the liver. 10 Stimulate pancreas to secrete insulin. 11 Drug to drug interaction with NSAIDS. Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance) Avandia Januvia Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix) Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus) Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) glipizide Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl) Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance
Créer jeu